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The major site of hematopoiesis transitions from the fetal liver to the spleen and bone marrow late in fetal
development. To date, experiments have not been performed to evaluate functionally the migration and seeding of
hematopoietic stem cells (HSCs) during this period in ontogeny. It has been proposed that developmentally timed
waves of HSCs enter the bloodstream only during distinct windows to seed the newly forming hematopoietic organs.
Using competitive reconstitution assays to measure HSC activity, we determined the localization of HSCs in the mid-to-
late gestation fetus. We found that multilineage reconstituting HSCs are present at low numbers in the blood at all
timepoints measured. Seeding of fetal bone marrow and spleen occurred over several days, possibly while stem cell
niches formed. In addition, using dual-chamber migration assays, we determined that like bone marrow HSCs, fetal
liver HSCs migrate in response to stromal cell-derived factor-1a (SDF-1a); however, unlike bone marrow HSCs, the
migratory response of fetal liver HSCs to SDF-1a is greatly increased in the presence of Steel factor (SLF), suggesting an
important role for SLF in HSC homing to and seeding of the fetal hematopoietic tissues. Together, these data
demonstrate that seeding of fetal organs by fetal liver HSCs does not require large fluxes of HSCs entering the fetal
bloodstream, and that HSCs constitutively circulate at low levels during the gestational period from 12 to 17 days
postconception. Newly forming hematopoietic tissues are seeded gradually by HSCs, suggesting initial seeding is
occurring as hematopoietic niches in the spleen and bone marrow form and become capable of supporting HSC self-
renewal. We demonstrate that fetal and adult HSCs exhibit specific differences in chemotactic behavior. While both
migrate in response to SDF-1a, fetal HSCs also respond significantly to the cytokine SLF. In addition, the combination
of SDF-1a and SLF results in substantially enhanced migration of fetal HSCs, leading to migration of nearly all fetal
HSCs in this assay. This finding indicates the importance of the combined effects of SLF and SDF-1a in the migration of
fetal HSCs, and is, to our knowledge, the first demonstration of a synergistic effect of two chemoattractive agents on
HSCs.
Introduction
During fetal development, the primary anatomical con-
centration of hematopoietic stem cells (HSCs) changes
location several times. The migration of blood-borne
progenitors is essential for the establishment of hematopoi-
esis in subsequent hematopoietic tissues (Moore and Metcalf
1970; Johnson and Moore 1975; Weissman et al. 1978;
Houssaint 1981; Weissman 2000; Akashi and Weissman
2001). The speculation that this fetal migration process
occurs as a series of distinct, timed developmental events,
wherein large numbers of fetal HSCs simultaneously enter
the bloodstream to seed newly forming hematopoietic organs,
arose from observations that a decrease in HSCs and/or
hematopoietic progenitor numbers in primary hematopoietic
tissues occurs just prior to the seeding of newly forming
hematopoietic sites (Morrison et al. 1995; Medvinsky and
Dzierzak 1996). Hematopoietic precursor numbers increase
in intraembryonic sites such as the aorta–gonad–mesene-
pheros region (AGM) and yolk sac until 11 days postconcep-
tion (dpc), then decrease, becoming undetectable by 13 dpc
(Moore and Metcalf 1970; Muller et al. 1994; Garcia-Porrero
et al. 1995; Sanchez et al. 1996; Godin et al. 1999). This
decrease in HSC numbers is hypothesized to result from a
wave of multipotent progenitors leaving the AGM (Medvinsky
and Dzierzak 1996) or yolk sac (Weissman et al. 1978) to seed
the fetal liver on 11 dpc. However this occurs, HSCs increase
exponentially in the fetal liver from day 12 until day 15 (Ikuta
and Weissman 1992; Morrison et al. 1995) or day 16 (Ema and
Nakauchi 2000); then, HSC numbers and activity in the fetal
liver decrease, although the fetal liver HSC (FL HSC)
population continues to proliferate at an equivalent rate.
This decrease in HSC numbers in the fetal liver could result
from a mobilization of HSCs from the fetal liver to the spleen
and bone marrow (Morrison et al. 1995).
While the mechanisms that inﬂuence HSC homing and
colonization are not completely understood, several exper-
imental models suggest possible regulatory factors. The
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PLoS BIOLOGYhoming to and colonization of fetal hematopoietic organs by
circulating HSCs likely require homing receptor/addressin
interactions in the vascular lumen, followed by chemokine/
chemokine receptor interactions, integrin/receptor binding,
and growth/survival factors. Homing of lymphocytes and
leukocytes has been well documented to involve ﬁrst homing
receptor/vascular addressin interactions, resulting in cell
tethering and rolling on blood vessel endothelium. The
rolling cells respond to a chemoattractant, produced by
endothelial or stromal cells within the tissue, by ﬁrm
adherence to the vessel wall mediated by integrin/receptor
interactions. The adhered cells subsequently traverse the
vessel wall, migrating toward the increasing gradient of
chemoattractant (Butcher and Weissman 1980; Gallatin et al.
1983; Springer 1990; Campbell et al. 1998). A similar cascade
of interactions is likely to govern the migration of immature
hematopoietic stem/progenitor cells. Mice born with genetic
deﬁciency of the chemokine stromal cell-derived factor-1a
(SDF-1a), or its receptor, CXCR4, fail to establish bone
marrow hematopoiesis, although fetal liver hematopoiesis is
normal (Nagasawa et al. 1996; Zou et al. 1998; Ara et al. 2003).
In addition, bone marrow HSCs (BM HSCs) have been shown
to migrate selectively in vitro in response to SDF-1a (Wright
et al. 2002). SDF-1a may be important both as a chemo-
attractant (Imai et al. 1999; Peled et al. 1999) and as an
activator of adhesion molecules on HSCs (Peled et al. 2000)
and may function in the retention and maintenance of fetal
HSCs once they reach the hematopoietic niche (Nagasawa et
al. 1998; Tachibana et al. 1998; Zou et al. 1998; Kawabata et al.
1999; Ma et al. 1999; Lataillade et al. 2000).
Correct localization of HSCs throughout ontogeny may
also involve other speciﬁc interactions with the hemato-
poietic microenvironment (Schweitzer et al. 1996). A factor
that is well-established to be important to the maintenance,
survival and proliferation of HSCs is Steel factor (SLF)
(Broxmeyer et al. 1991; Metcalf and Nicola 1991; Ikuta and
Weissman 1992; Li and Johnson 1994; Keller et al. 1995;
Holyoake et al. 1996; Goff et al. 1998; Domen et al. 2000).
Homozygous deﬁciency mutations of the SLF-encoding gene
(Sl), normally expressed in hematopoietic stromal cells, or its
receptor gene (W), encoding the c-Kit tyrosine kinase, result
in profound but incomplete defects in hematopoiesis (Russell
1979). Functional hematopoietic cells from Steel ligand-
deﬁcient mice (Sl/Sl
d) can be rescued by transplantation to a
wild-type host (McCulloch et al. 1965; Fried et al. 1973; Dexter
and Moore 1977; Bernstein et al. 1991; Barker 1997).
Interestingly, in the lethal Sl/Sl background, FL HSCs double
their number daily between 13 and15 dpc (Ikuta and
Weissman 1992), indicating that factors other than SLF are
responsible for fetal HSC expansion. SLF has also been
implicated as a chemotactic factor of human (Kim and
Broxmeyer 1998) and mouse (Okumura et al. 1996) hema-
topoietic progenitor cells.
In order to test the hypothesis that fetal HSC migration is a
timed developmental event, we collected blood from embryos
ranging in age from 12.5 to 17.5 dpc to use in competitive
reconstitution assays to measure long-term reconstituting
hematopoietic stem cell (LT-HSC) activity. Our results
indicate that mouse fetal HSCs are found constitutively
rather than episodically in fetal circulation and are present at
low numbers throughout mid-to-late fetal development. We
also measured the seeding of the fetal spleen and fetal bone
marrow during this period. The seeding of these organs is a
gradual process occurring over several days and does not
appear to involve a large inﬂux of HSC. Finally, we found that
FL HSCs migrate in response to the chemokine SDF-1a and
that this response is substantially enhanced in the presence of
SLF. The enhanced chemotactic response of HSCs to the
combination of SLF and SDF-1a is a property of FL HSCs, but
not adult BM HSCs.
Results
HSC Are Found Constitutively Circulating in Fetal Blood
To evaluate the presence of rare HSC activity in the fetal
circulation, blood was collected from fetuses ranging in age
from 12.5 to 17.5 dpc. Blood from a single age group was
pooled and assayed by competitive reconstitution. A quantity
of fetal cells, measured by fetus equivalents (FEs), was injected
into an adult, lethally irradiated congenic recipient, along
with a radioprotective dose of host-type bone marrow. A FE
was deﬁned as the amount of blood collected from a single
fetus of each age group. The amount of fetal blood
transplanted ranged from 4 FE to 0.1 FE. The recipient mice
were periodically bled and assayed for donor cells of the B, T,
and myeloid lineages. Table 1 demonstrates that stem cells
capable of long-term multilineage reconstitution (LT-MLR)
are found constitutively in the fetal blood throughout the
time period assayed, from 12.5 to 17.5 dpc. Figure 1A
illustrates the level of donor-derived peripheral blood cells
at 20 wk or more. LT-HSC activity is maintained at low but
fairly constant levels throughout this time period, with a
minor peak apparent at 14.5 dpc (Figure 2). Consistent with
these results, cells that display the fetal liver stem cell surface
phenotype, c-Kit
þ Thy-1.1
lo Sca-1
þ Lineage
– Mac-1
lo (Morri-
son et al. 1995) can be detected by FACS in fetal circulation at
both 14.5 and 17.5 dpc (Figure 3).
Seeding of Fetal Spleen and Bone Marrow by HSCs
To measure the kinetics of seeding of the fetal spleen and
bone marrow by HSCs, these tissues were similarly assayed by
competitive reconstitution for LT-HSC activity. Spleens were
collected from 14.5 to 17.5 dpc and fetal bone marrow from
15.5 to 17.5 dpc. For these experiments, a FE was deﬁned as
the number of cells collected from a single fetal spleen or
bone marrow collected from two femurs plus two tibia. Table
2 illustrates the initiation of long-term multipotent progen-
itor activity in the fetal spleen and fetal bone marrow. Figures
1B and 1C illustrate the levels of donor-derived peripheral
blood cells at 20 wk or more in recipient animals transplanted
with fetal spleen or bone marrow cells. Active seeding of the
spleen by LT-HSCs occurs at approximately 15 dpc, although
infrequent LT-HSCs can be found in 14.5 dpc spleen when
multiple embryo equivalents are assayed by transplantation,
indicating that very few HSCs initially seed this organ. HSC
activity increases daily in the spleen during the period
assayed, from 14.5 to 17.5 dpc. While LT-HSC activity is
absent from the fetal marrow at the time, it is robustly
established in the spleen at 15.5–16.5 dpc. LT-HSC activity
can ﬁrst be detected in the fetal bone marrow at 17.5 dpc.
However, when it is established at 17.5 dpc, the initial seeding
of the bone marrow is quite robust (see Figure 1C; Table 2),
especially given that the amount of bone marrow assayed may
only represent approximately 20% of the total bone marrow
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as it is in the adult (Smith and Clayton 1970) . The number of
spleen HSCs continues to increase as bone marrow colo-
nization proceeds. The appearance of long-term reconstitut-
ing activity correlates with visible active erythropoiesis in
both tissues (data not shown). HSCs identiﬁed by FACS in
17.5 dpc fetal spleen and bone marrow have the FL HSC
phenotype, c-Kit
þ Thy-1.1
lo Sca-1
þ Lineage
– Mac-1
lo (Morri-
son et al. 1995; see Figure 3). Within the 14.5 dpc fetal spleen
and 15.5 dpc fetal bone marrow are mainly hematopoietic
cells that give rise to a burst of B lymphopoiesis but do not
provide sustained or detectable myelopoiesis upon transplant
to adult recipients (Figure 4). This likely indicates a rapid
commitment of HSCs and multipotent progenitors to
common lymphoid progenitors or prepro-B cells upon
seeding these microenvironments, although it could repre-
sent early seeding of these sites selectively by committed
progenitor cells rather than HSCs. An alternate, though less
likely, explanation is that 14.5 dpc splenic HSCs and 15.5–16.5
dpc BM HSCs are unable to seed the adult environment. In
both sites, the likely origin of the immigrant cells is the fetal
liver, as HSCs are no longer resident in the yolk sac and AGM
at this time (Moore and Metcalf 1970; Muller et al. 1994;
Garcia-Porrero et al. 1995; Sanchez et al. 1996; Godin et al.
1999).
Synergistic Effects of SDF-1a and SLF on Chemotaxis of
Fetal HSCs
To begin to assess whether SDF-1a or SLF may play a direct
role in fetal HSC migration, we assayed the ability of FL HSCs
to migrate in response to SDF-1a and/or SLF in dual-chamber
migration assays. Lineage-depleted fetal liver or adult bone
marrow cells were placed in the upper well of a 5-lm
transwell chamber, and SDF-1a, SLF, or SDF-1a plus SLF was
added to the lower chamber. To evaluate the chemotactic
versus chemokinetic effects of SDF-1a and SLF, equal
concentrations of factors were added to both the top and
bottom chambers. Following a 2 h incubation at 378C, the
cells that had migrated to the lower chamber were collected,
stained for HSC markers, and analyzed by FACS to determine
the actual number of migrated HSCs. Cell numbers between
wells were normalized by the addition of predetermined
numbers of ﬂuorescent beads to each well before cell
collection (Wright 2002). Like adult BM HSCs, 14.5 dpc FL
HSCs migrate in response to a gradient of SDF-1a, albeit at a
reduced frequency (Figure 5A). Both FL HSCs and adult BM
HSCs displayed an optimal migratory response to SDF-1a at
10 nM. In addition, FL HSCs, but not adult BM HSCs, showed
substantial migration, above basal activity, in response to 10
nM SLF. The combination of SLF and SDF-1a had a
synergistic affect on the migratory response of FL HSCs,
with 70%–90% of the input HSC responding. The increased
migration of adult BM HSCs in response to SDF-1a and SLF,
above that seen in response to SDF-1a alone, was more
modest. Migration in response to SDF-1a of both FL HSCs
and adult BM HSCs was largely dependent on the presence of
a chemokine gradient (Figure 5B). In contrast, the migration
of adult HSCs induced by SDF-1a plus SLF appeared to
involve both chemotactic and chemokinetic activity, as
inclusion of factors in both the top and bottom of the
transwell did not entirely abrogate HSC migration (Figure
5B).
Discussion
As reported previously, HSCs in the fetal liver double in
number daily from 12.5 to14.5 dpc, then decrease in number
at 15.5 dpc (Ikuta and Weissman 1992; Morrison et al. 1995).
At 12.5 dpc, approximately 1,200 HSCs are present, 2,430 at
13.5 dpc, and 5,100 at 14.5 dpc. However, rather than
doubling to 10,200, only 4,350 FL HSCs are found at 15.5
dpc (Morrison et al. 1995). This failure of FL HSCs to
continue doubling their numbers from day 14.5 to day 15.5 is
unexpected, because the same percentage of HSCs remained
as actively in cycle on day 15.5 as on day 14.5 (Morrison et al.
1995). Thus, about 5,800 HSCs are ‘‘missing’’ from the 15.5
dpc liver, possibly because they migrated via the blood to seed
the spleen or bone marrow. In order to test this hypothesis
quantitatively, we assayed fetal blood, spleen, and bone
marrow for HSC activity. However, our results indicate that
HSCs are found in the fetal blood at low but fairly constant
levels during much of late fetal development. Furthermore,
Table 1. Fetal Blood Titration
Age (dpc) Amount
Transplanted (FE)
Number of
LT-MLR
12.5 4.0 2/3
2.5 4/5
2.0 1/2
1.0 6/12
0.5 0/8
0.1 2/5
13.5 1.5 4/5
1.0 4/4
0.5 7/9
0.3 3/4
0.1 2/8
14.5 1.0 9/9
0.5 4/4
0.3 1/3
0.1 2/9
15.5 1.0 6/10
0.5 2/8
0.1 1/7
16.5 1.0 7/9
0.5 2/8
0.1 1/8
17.5 1.0 7/9
0.5 2/8
0.1 0/9
Cell suspensions of fetal blood were used to competitively reconstitute lethally
irradiated recipients. The fraction of mice exhibiting LT-MLR (B plus T lymphoid and
myeloid) for greater than 20 wk, for each dose of fetal blood, is presented.
DOI: 10.1371/journal.pbio.0020075.t001
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Circulation and Chemotaxis of Fetal HSCsFigure 1. LT-HSC Activity Is Measureable in
Fetal Blood, Spleen, and Bone Marrow
Cell suspensions of fetal blood (A),
spleen (B), and bone marrow (C) were
used to competitively reconstitute le-
thally irradiated recipients. The percent-
age of donor-derived peripheral blood
leukocytes is presented for each dose
assayed at 20 wk or more following
reconstitution. The bar represents the
mean percentage of donor-derived pe-
ripheral blood leukocytes in all recipi-
ents transplanted with each dose of fetal
tissue, blood, spleen, or bone marrow.
Fetal tissue from each stage embryo
(12.5–17.5 dpc) was transferred in two
to three experiments at multiple doses.
Positive engraftment was determined by
comparison to staining of control mice,
which in most cases was less than 0.1%.
DOI: 10.1371/journal.pbio.0020075.g001
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Circulation and Chemotaxis of Fetal HSCswe were unable to ﬁnd evidence of a large inﬂux of HSCs into
the fetal spleen and bone marrow at this timepoint. The
seeding of the fetal spleen and bone marrow is progressive
and does not appear to be the result of a large, devel-
opmentally timed migration. Thus, the decrease in FL HSC
numbers at 15.5 dpc is more likely explained by their
differentiation out of the HSC pool; this may be due to the
onset of hepatic differentiation in the fetal liver and an
induction of hepatic growth factors (Kinoshita et al. 1999).
Initiation of differentiation of HSCs to multipotent and
oligopotent progenitors at 15 dpc may account for the
increase in colony-forming unit–spleen (CFU-S) activity (a
mixture of HSCs, multipotent progenitors, common myeloid
progenitors, and megakaryocyte/erythrocyte-restricted pro-
genitors [Na Nakorn et al. 2002]) in the fetal liver at 17 dpc,
observed in other studies (Niewisch et al. 1970; Wolf et al.
1995) at this and later timepoints, that occurs despite the
decreasing number of HSCs in the liver following 15.5 dpc
(Morrison et al. 1995; Ema and Nakauchi 2000). HSCs are
found in the blood after the establishment of active
circulation at 9 dpc (Toles et al. 1989) and are present in
Figure 2. LT-HSC Activity Is Detectable in Fetal Blood (12.5–17.5 dpc)
To illustrate an increase in circulating HSCs at 14.5 dpc, the
percentage of recipients with donor multilineage reconstitution
from fetal blood are plotted for each timepoint (12.5–17.5 dpc), for
1.0 and 0.5 FE.
DOI: 10.1371/journal.pbio.0020075.g002
Figure 3. Phenotypic Analysis of HSC in
Fetal Blood, Spleen, and Bone Marrow
Cells can be identiﬁed in fetal circula-
tion, spleen, and bone marrow with the
FL HSC phenotype: Lineage
– c-Kit
þSca-
1
þ Thy-1.1
lo Mac-1
lo. At 14.5 and 17.5
dpc, fetal tissues were analyzed for
Lineage
– c-Kit
þ Sca-1
þ Thy-1.1
lo and
Mac-1
lo expression. The leftmost con-
tour plot shows Lineage versus Thy-1.1
staining of live cells. The middle plot
shows c-Kit versus Sca-1 staining for
gated Lineage
–/lo Thy-1.1
lo cells. The
rightmost histogram shows Mac-1 ex-
pression by gated Lineage
–/lo Thy-1.1
lo
Sca-1
þ c-Kit
þ cells. Fetal liver, blood,
spleen, and BM HSCs have low-level
Mac-1 expression. These data are repre-
sentative of three independent experi-
ments.
DOI: 10.1371/journal.pbio.0020075.g003
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Circulation and Chemotaxis of Fetal HSCsthe fetal blood at all times following the onset of circulation.
As reported by Kumaravelu et al. (2002), we see an increase in
circulating HSCs between 12 and 13 dpc. In adults, the
residence time of HSCs in the blood is about 1–3 min (Wright
et al. 2001). If this is likewise true in fetuses, then long-term
reconstitution is likely an accurate measure of HSC ﬂux
during fetal life. Alternatively, if the transit time of blood-
borne HSCs decreases at 15 dpc and migrating HSCs lose
long-term repopulating potential upon initial seeding of the
spleen, we may have been unable to measure such a
developmentally timed migration.
As measured by reconstitution, a slight peak of circulating
embryonic HSCs appears at 14.5 dpc. The slight decrease of
circulating HSCs at 15.5 dpc could also be due to HSCs
leaving the circulation to seed the spleen and later the bone
marrow. The fetal spleen and bone marrow are initially
seeded by progenitors unable to provide detectable or
sustained myelopoiesis, indicating additional requirements
not found in these immature hematopoietic tissues are
needed for LT-HSC seeding, maintenance, or both. Our data
indicate that fetal liver-derived HSCs (c-Kit
þ Thy-1.1
lo
Lineage
– Sca-1
þ Mac-1
lo) begin to seed the fetal spleen and
bone marrow on 14.5–15 dpc and 17.5 dpc, respectively. We
propose that fetal HSCs are continuously entering circulation
and functionally engraft specialized stem cell niches as they
develop (Figure 6).
Our results stand in contrast with those previously
reported by Delassus and Cumano (1996) and Wolber et al.
(2002). Using an in vitro differentiation system, Delassus and
Cumano (1996) reported that blood multipotent activity is
present in the fetal blood from 10 dpc to 12 dpc and then
becomes undetectable. Likewise, we were unable to detect a
decrease in circulating HSCs between 13–15 dpc, as reported
by Wolber et al (2002), measured by CFU-S. We utilized a
competitive reconstitution assay, which is the most stringent
and reliable indicator of LT-HSC activity to assay function-
ally for LT-HSCs in fetal circulation. We were able to detect
circulating HSCs throughout the period measured, 12.5–17.5
dpc.
Studies indicate that HSC trafﬁcking to and retention in
the bone marrow relies on the chemokine SDF-1a and its
receptor CXCR4 (Aiuti et al. 1997; Dutt et al. 1998; Kim and
Broxmeyer 1998; Kawabata et al. 1999; Ma et al. 1999; Peled et
al. 1999; Ara et al. 2003). We have previously shown that BM
HSCs migrate only in response to SDF-1a, a large panel of
chemokines (Wright et al. 2002). However, a recent study
indicated that 11 dpc c-Kit
þ fetal liver hematopoietic
progenitor cells respond poorly to SDF-1a (Mazo et al.
2002). The discrepancy between our results and those of Mazo
et al. may relate to differences in the developmental stage of
the cells examined or to differences between HSCs and
progenitors. At 11 dpc, the fetal liver is beginning to be
seeded, and based on knockout studies, SDF-1a is not
required for seeding of the fetal liver (Kawabata et al.
1999). In contrast, our study demonstrates clearly that 14.5
dpc FL HSCs do migrate in response to SDF-1a, although at a
reduced frequency as compared to adult BM HSC chemotaxis
to SDF-1a.
We also found that the migratory response of fetal HSCs to
SLF was equal to the response to SDF-1a. The migratory
response of fetal HSCs to SDF-1a in combination with SLF
was synergistic. This ﬁnding indicates the importance of the
synergistic effects of SLF and SDF-1a in the migration of fetal
HSCs. In contrast, SLF alone or in combination with SDF-1a
did not evoke a greatly enhanced migratory response from
adult BM HSCs. At best, the combination of SLF and SDF-1a
Table 2. Fetal Spleen and Bone Marrow Titration
Age (dpc) Spleen Bone Marrow
Amount Transferred (FE) Number of LT-MLR Amount Transferred (FE) Number of LT-MLR
14.5 2.0 2/5 Not transferred
1.0 0/9
0.5 0/4
0.1 0/4
15.5 1.0 4/10 2.0 0/4
0.5 2/9 1.0 0/8
0.1 0/9 0.5 0/3
0.1 0/3
16.5 0.5 7/8 2.0 0/3
0.1 4/10 1.0 0/9
0.05 1/7 0.5 0/2
0.1 0/4
17.5 0.5 3/3 1.0 7/8
0.1 5/8 0.5 6/8
0.05 5/8 0.1 1/9
0.01 1/4
Cell suspensions of fetal spleen or bone marrow were used to competitively reconstitute lethally irradiated recipients. The fraction of mice exhibiting LT-MLR for greater than
20 wk is presented for each dose of fetal spleen or marrow.
DOI: 10.1371/journal.pbio.0020075.t002
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BM HSCs. A synergistic effect of two chemoactive agents has
not, to our knowledge, been directly demonstrated before for
HSCs. The substantial migratory response of 14.5 dpc FL
HSCs to the combination of SLF and SDF-1a could explain
the increased severity of the Steel mutant phenotype for bone
marrow versus fetal liver hematopoiesis (Ikuta and Weissman
1992). The late embryonic lethality seen in the Sl/Sl mutant
may be due to the inability of FL HSCs to efﬁciently seed the
bone marrow. The chemotactic response to these factors by
14.5 dpc fetal HSC may also underlie the superior recon-
stituting ability of FL HSCs (Morrison et al. 1995; Rebel et al.
1996), as SLF is released by bone marrow cells following
cytoreductive injury and thus may enhance recruitment of
infused FL HSCs over adult BM HSCs, which do not respond
to SLF.
Our lab has recently described a physiological process in
which low numbers of BM HSCs rapidly but constitutively
traverse the bloodstream of normal mice to seed unoccupied
bone marrow niches (Wright et al. 2001). We now propose
that this process, which may serve to survey barren niches in
adult bone marrow, also functions to seed newly forming fetal
hematopoietic tissues as suitable microenvironments develop.
Protocols that induce mobilization of HSCs for clinical
hematopoietic cell transplantation may mimic mechanisms,
already in place, that allow naturally occurring migration and
engraftment of HSCs in the fetus and adult. Further
investigation into the mechanisms that regulate these
naturally occurring migrations may yield both an improved
understanding of the importance of HSC migrations for
hematopoietic development and improved protocols for
clinical bone marrow transplants.
Materials and Methods
Mouse strains. The C57BL/Ka-Thy-1.1/Ly-5.2 (Thy-1.1, Ly-5.2)
donor and C57BL/Ka-Thy-1.2 (Thy-1.2, Ly-5.1) recipient mouse
strains were bred and maintained at the Stanford University
Laboratory Animal Facility, Stanford, California, United States. All
mice were routinely maintained on acidiﬁed water (pH 2.5).
Irradiated recipient mice were more than 8 wk old at the time of
irradiation. All protocols were approved by the Administrative Panel
Figure 4. Progenitors Are Found in the Fetal Spleen and Bone Marrow
Prior to Colonization by LT-HSC
Seeding of the fetal spleen (A) and bone marrow (B) by progenitors
unable to provide sustained myelopoiesis precedes colonization of
these tissues by HSCs. Reconstituted mice were analyzed for donor
contribution in the peripheral blood of B, T, and myeloid lineages at
4 wk post-transplant. Contour plots show gating of donor (Ly-5.2
þ)
cells and analysis of B220 (B cell) versus Mac-1 (myeloid cell) markers
on donor cell populations. At 14.5 dpc, progenitors able to give rise
only to B cells were detectable from the fetal spleen in trans-
plantation assays; three of eight recipients receiving 1.0 FE 14.5 dpc
fetal spleen cell suspension had donor B cell readout; zero of nine
recipients receiving 1.0 FE 14.5 dpc fetal spleen cell suspension LT-
MLR. B cell progenitors were detectable from the fetal bone marrow
at 15.5 dpc (one of ﬁve receiving 2.0 FE) and 16.5 dpc (one of eight
receiving 1.0 FE), before detectable HSCs were present. Fetal tissue
from each stage embryo (12.5–17.5 dpc) was transferred in two to
three experiments at multiple doses. Positive engraftment was
determined by comparison to staining of control mice, which in
most cases was less than 0.1%.
DOI: 10.1371/journal.pbio.0020075.g004
Figure 5. Chemotactic Activity of SDF-1a and SLF on Fetal Liver and
Adult BM HSCs
HSCs were assayed for their ability to chemotax in a transwell assay in
response to the chemokine SDF-1a. Migrating cells were labeled with
stem cell markers and analyzed by FACS to determine the actual
frequency of migrated HSCs. Like adult BM HSCs, FL HSCs migrate
in response to SDF-1a (A), although at reduced levels. The optimal
concentration of SDF-1a for both fetal liver and adult BM HSCs was
determined to be 10 nM. The migratory effect of SLF was also assayed
on FL HSCs and adult BM HSCs. FL HSCs migrate equally well to SLF
as SDF-1a, while adult BM HSCs showed a lesser response to SLF. SLF
and SDF-1a acted synergistically in their chemoattractive effects on
FL HSCs (B). To determine whether migration was due to chemo-
kinetic effects of SDF-1a, SLF, or both, equal concentrations of
factors were added to both the top and bottom wells (T&B). Data are
presented as the percentage of input HSCs that migrate to the
bottom chamber for a representative migration assay, each point was
performed in triplicate. These data are representative of three
independent experiments. The single asterisk shows a signiﬁcant
increase in percent migration over basal migration (p , 0.05). The
double asterisk shows a signiﬁcant increase in percent migration over
SDF-1a alone.
DOI: 10.1371/journal.pbio.0020075.g005
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Antibodies. A20.1 (anti-Ly-5.1, CD45.2, FITC-conjugated; BD
Biosciences [Pharmingen], Palo Alto, California, United States) and
AL1-4A2 (anti-Ly-5.2, CD45.1, Texas Red conjugate) were used to
analyze donor and host cells following reconstitution. Blood analysis
included 6B2 (anti-B220), KT31.1 (anti-CD3), GK1.5 (anti-CD4), 53-6.7
(anti-CD8), 8C5 (anti-Gr-1), and M1/70 (anti-Mac-1).
The monoclonal antibodies used in immunoﬂuorescence staining
for HSC analysis included 2B8 (anti-c-Kit, APC conjugate), 19XE5
(anti-Thy-1.1, FITC conjugate), E13 (anti-Sca-1, Ly6A/E, Texas Red
conjugate), and M1/70 (anti-Mac-1, PE conjugate). Lineage marker
antibodies included 6B2 (anti-B220), KT31.1 (anti-CD3), GK1.5 (anti-
CD4), 53-7.3 (anti-CD5), 53-6.7 (anti-CD8), Ter119 (anti-erythrocyte-
speciﬁc antigen), 8C5 (anti-Gr-1), and M1/70 (anti-Mac-1). The
antibodies were puriﬁed and conjugated within our lab. Each
antibody was titrated and used at predetermined optimal concen-
trations (highest signal with lowest background following staining of
control spleen or bone marrow cells).
Fetal Tissue Preparation. Timed pregnancies of C57BL/Ka-Thy-1.1/
Ly-5.2 mice were used to obtain embryos. The day the vaginal plug
was observed was designated as 0.5 dpc. The uterus was removed and
washed to remove maternal blood. Fetuses were carefully removed to
prevent contamination with maternal blood. Fetuses were then
decapitated in Hanks’ balanced salt solution containing 5 mM EDTA
and allowed to bleed out. Fetuses were passaged through several
dishes of media until completely pale. Blood was combined and
centrifuged. Blood was either prepared for injection by sedimenting
RBCs in dextran followed by lysis of erythrocytes in 0.15 M
ammonium chloride, 0.01 M potassium bicarbonate solution on ice,
or remained unmanipulated and was injected directly into recipients.
Results from both preparations were comparable. Spleens were
obtained by ﬁrst removing the spleen and stomach to a dish of Hanks’
balanced salt solution containing 2% FBS. The spleens were then
peeled from the surface of the stomach and placed in a clean dish of
media. Femurs and tibia were removed and cleaned of muscle tissue.
Spleens and bone were dissociated using the rubber end of a 1 ml-
syringe plunger and ﬁltered through nylon mesh. Blood and tissues
were collected from fetuses obtained from at least three pregnant
females for each timepoint measured. Fetuses that appeared
developmentally advanced or delayed in any age group were
discarded.
Competitive reconstitution. Adult recipient mice were lethally
irradiated with a split dose of 950 rad as previously described
(Morrison and Weissman 1994). Recipient mice were anesthetized
with 3% isoﬂurane. Fetal cells were transferred by retroorbital
injection along with a radioprotective dose of 3310
5 CD45 congenic
(recipient-type) whole bone marrow cells. Recipient mice were
periodically bled to analyze peripheral blood for donor B and T
lymphocytes and myeloid cells. Recipients were determined to have
LT-MLR if all three of these donor subsets were present for greater
than 20 wk. Positive engraftment was determined by comparison to
control mice, and in most cases the threshold for positivity was less
than 0.1%.
Chemotaxis assays. FL HSCs and adult BM HSCs were prepared as
for antibody staining. Cells were stained with a lineage cocktail of the
same puriﬁed rat IgG monoclonal antibodies used for FACS sorting.
The cells were then depleted by magnetic selection using anti-rat IgG
beads as per manufacturer’s instructions (Dynal Biotech, Oslo,
Norway), followed by a 1h incubation in RPMI media (GIBCO-BRL,
San Diego, California, United States) containing 10% FBS in a tissue
culture ﬂask at 378C to remove adherent cells. Dual-chamber
chemotaxis assays were performed using 24-well plates with 5-lm
pore size inserts (Costar/Corning, Corning, New York, United States),
as previously described (Wright et al. 2002). SDF-1a-containing
medium (PeproTech, Rocky Hill, New Jersey, United States) or SLF-
containing medium (R & D Systems, Minneapolis, Minnesota, United
States) was added to the lower chamber, and 100 ll of a cell
suspension (5 3 10
6 or 1 3 10
7 cells/ml) of lineage-depleted cells was
placed in the upper chamber. To measure chemokinetic movement,
factors were also added to the upper chamber at the same
concentration as the lower chamber. Following a 2 h incubation,
the upper chamber was removed. A known quantity of ﬂuorescent
beads was added to the lower chamber for normalization of migrated
HSCs. Migrated cells were removed from the lower chamber and
stained with PE-conjugated antirat IgG. After washing, cells were
incubated with rat IgG and then labeled with directly conjugated
lineage PE, c-Kit APC, Sca-1 Texas Red and Thy-1.1 FITC antibodies.
Cells were analyzed by FACS to enumerate migrated HSCs.
Statistics. Results shown in Figure 5 represent the mean plus the
standard deviation. Signiﬁcant differences were determined using a
two-tailed Student’s t-test. A p value of ,0.05 was considered
signiﬁcant.
Supporting Information
Accession Numbers
The LocusLink (www.ncbi.nlm.nih.gov/LocusLink/) accession numbers
of the gene products discussed in this paper are CXCR4 (LocusLink
ID 12767), SDF-1a (LocusLink ID 20315), and SLF (LocusLink ID
17311).
Acknowledgments
We thank L. Jerabek for laboratory management, S. Smith for
antibody preparation, and L. Hidalgo and D. Escoto for animal care.
This work was supported by National Institutes of Health (NIH) grant
5R01 HL-58770 to ILW, NIH Training Grant in Molecular and
Cellular Immunobiology 5T32AI07290-16 to JLC, National Institute
of Allergy and Infectious Diseases training grant 5T32 AI-07290 to
DEW, and American Cancer Society Grant PF-00-017-LBC to AJW.
Conﬂicts of interest. JLC is currently employed by and has stock
options in Cellerant Therapeutics, a company seeking to transplant
human HSCs. As a former advisory board member of Amgen, ILW
owns signiﬁcant Amgen stock. He also cofounded and consulted for
Systemix; cofounded Cellerant Therapeutics, a spin-off from System-
ix Novartis to transplant human HSCs; and is a cofounder and a
director of Stem Cells, Inc., which is involved in the isolation and
study of human central nervous system stem cells, liver-repopulating
cells, and pancreatic islet stem/progenitor cells.
Author contributions. JLC, DEW, and AJW conceived and designed
the experiments. JLC, DEW, and AJW performed the experiments.
JLC, DEW, and AJW analyzed the data. JLC wrote the paper. ILW
assisted in the analysis of the data and reviewed the manuscript. &
Figure 6. An Updated Model Illustrating the Location and Relative
Frequencies of Fetal HSCs in the Embryo
HSCs are found constitutively at low numbers in fetal blood following
the onset of circulation. Seeding of developing hematopoietic tissues
by long-term HSCs is gradual and is not due to a large inﬂux of cells.
The large decline in HSC numbers seen in the fetal liver following 14
dpc is most likely the result of differentiation signaled by the
developing hepatic environment rather than a timed migration to the
fetal spleen and bone marrow.
DOI: 10.1371/journal.pbio.0020075.g006
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